These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 38886750)

  • 1. Accounting for center-level effects in multicenter randomized controlled trials.
    Islam S; Bangdiwala SI
    Trials; 2024 Jun; 25(1):390. PubMed ID: 38886750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accounting for center in the Early External Cephalic Version trials: an empirical comparison of statistical methods to adjust for center in a multicenter trial with binary outcomes.
    Reitsma A; Chu R; Thorpe J; McDonald S; Thabane L; Hutton E
    Trials; 2014 Sep; 15():377. PubMed ID: 25257928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study.
    Dechartres A; Boutron I; Trinquart L; Charles P; Ravaud P
    Ann Intern Med; 2011 Jul; 155(1):39-51. PubMed ID: 21727292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating relative risks in multicenter studies with a small number of centers - which methods to use? A simulation study.
    Pedroza C; Truong VTT
    Trials; 2017 Nov; 18(1):512. PubMed ID: 29096682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison between traditional methods and multilevel regression for the analysis of multicenter intervention studies.
    Moerbeek M; van Breukelen GJ; Berger MP
    J Clin Epidemiol; 2003 Apr; 56(4):341-50. PubMed ID: 12767411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.
    Anglemyer A; Horvath HT; Bero L
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):MR000034. PubMed ID: 24782322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accounting for centre-effects in multicentre trials with a binary outcome - when, why, and how?
    Kahan BC
    BMC Med Res Methodol; 2014 Feb; 14():20. PubMed ID: 24512175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
    Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appropriate statistical methods for analysing partially nested randomised controlled trials with continuous outcomes: a simulation study.
    Candlish J; Teare MD; Dimairo M; Flight L; Mandefield L; Walters SJ
    BMC Med Res Methodol; 2018 Oct; 18(1):105. PubMed ID: 30314463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Many multicenter trials had few events per center, requiring analysis via random-effects models or GEEs.
    Kahan BC; Harhay MO
    J Clin Epidemiol; 2015 Dec; 68(12):1504-11. PubMed ID: 25985892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conceptual framework and systematic review of the effects of participants' and professionals' preferences in randomised controlled trials.
    King M; Nazareth I; Lampe F; Bower P; Chandler M; Morou M; Sibbald B; Lai R
    Health Technol Assess; 2005 Sep; 9(35):1-186, iii-iv. PubMed ID: 16153352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low patient enrollment sites in multicenter randomized clinical trials of cerebrovascular diseases: associated factors and impact on trial outcomes.
    Qureshi AI; Tariq N; Vazquez G; Novitzke J; Suri MF; Lakshminarayan K; Haines SJ
    J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):131-42. PubMed ID: 20719541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of multicenter clinical trials with very low event rates.
    Kim J; Troxel AB; Halpern SD; Volpp KG; Kahan BC; Morris TP; Harhay MO
    Trials; 2020 Nov; 21(1):917. PubMed ID: 33168073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review of prevention and intervention strategies for populations at high risk of engaging in violent behaviour: update 2002-8.
    Hockenhull JC; Whittington R; Leitner M; Barr W; McGuire J; Cherry MG; Flentje R; Quinn B; Dundar Y; Dickson R
    Health Technol Assess; 2012; 16(3):1-152. PubMed ID: 22330980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new population-enrichment strategy to improve efficiency of placebo-controlled clinical trials of antidepressant drugs.
    Merlo-Pich E; Alexander RC; Fava M; Gomeni R
    Clin Pharmacol Ther; 2010 Nov; 88(5):634-42. PubMed ID: 20861834
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.